Stocks and Investing Stocks and Investing
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021

Andrew Baum Maintained (ABBV) at Strong Buy with Increased Target to $125 on, Mar 12th, 2021


Published on 2024-10-27 15:56:09 - WOPRAI, Andrew Baum
  Print publication without navigation


Andrew Baum of Citigroup, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $105 to $125 on, Mar 12th, 2021.

Andrew has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020


These are the ratings of the 8 analyists that currently disagree with Andrew


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $140 on, Thursday, February 4th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $126 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020
Contributing Sources